Product image of Mel Med (Meloxicam) supplied by GNH India

Mel Med

Active Ingredient:
Meloxicam
Origin:
EU

Mel Med (Meloxicam)

Meloxicam, the active ingredient in Mel Med, is a NSAID (Oxicam) presented as a [strength]/[form] for oral use. It treats osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain and musculoskeletal pain in adults and children as appropriate.

GNH India supplies Mel Med as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Hasco-Lek

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meloxicam is indicated for inflammatory joint diseases and acute musculoskeletal pain.

  • Osteoarthritis: reduces joint pain and improves mobility in patients with degenerative joint disease.
  • Rheumatoid arthritis: alleviates inflammation and pain associated with chronic autoimmune arthritis.
  • Juvenile rheumatoid arthritis: provides symptom relief in pediatric patients with inflammatory arthritis.
  • Acute pain: offers rapid analgesia for short‑term painful conditions.
  • Musculoskeletal pain: eases pain from strains, sprains and other soft‑tissue injuries.

How It Works

  • Meloxicam selectively inhibits the cyclooxygenase‑2 (COX‑2) enzyme, decreasing the conversion of arachidonic acid to prostaglandins. By reducing prostaglandin synthesis, it diminishes inflammation, pain, and fever while sparing COX‑1 mediated protective gastric functions to a greater extent than non‑selective NSAIDs.

Side Effects

Adverse reactions may occur with meloxicam use.

Common Side Effects

  • Dyspepsia: upset stomach or indigestion.
  • Nausea: feeling of sickness or urge to vomit.
  • Headache: mild to moderate head pain.
  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Peripheral edema: swelling of the lower limbs.
  • Hypertension: increase in blood pressure.

Serious or Rare Side Effects

  • Gastrointestinal ulcer or bleeding: severe stomach or intestinal lesions.
  • Cardiovascular events: increased risk of heart attack or stroke.
  • Hepatic injury: signs of liver dysfunction such as jaundice.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Renal failure: sudden loss of kidney function.
  • Anaphylaxis: life‑threatening allergic reaction.

Precautions & Warnings

Before initiating meloxicam therapy, consider the following safety measures.

  • Renal function: monitor kidney parameters in patients with existing renal impairment.
  • Cardiovascular risk: use cautiously in individuals with a history of heart disease or stroke.
  • Gastrointestinal history: assess for prior ulcers or bleeding disorders.
  • Pregnancy and lactation: avoid unless the potential benefit outweighs the risk.
  • Concomitant medications: review use of other NSAIDs, anticoagulants, or corticosteroids.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Meloxicam can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): heightened risk of serious bleeding.
  • Other NSAIDs or aspirin: additive gastrointestinal toxicity.
  • Selective COX‑2 inhibitors: increased cardiovascular risk when combined.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: possible reduction in renal function.
  • Diuretics: may exacerbate renal impairment.
  • Lithium: meloxicam can raise serum lithium levels, requiring monitoring.
  • Methotrexate: potential for increased toxicity.
  • Cyclosporine: enhanced nephrotoxic risk.

Frequently Asked Questions

Mel Med contains meloxicam, an NSAID that is prescribed to relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain episodes, and musculoskeletal injuries such as sprains or strains.

Meloxicam works by selectively blocking the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. This selective inhibition helps control symptoms while sparing COX‑1 activity that protects the stomach lining.

The appropriate dose of Mel Med is determined by the prescribing clinician based on the patient’s condition, age, weight, renal and hepatic function, and response to therapy. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Meloxicam is generally not recommended during pregnancy, especially in the third trimester, because of potential risks to the fetus. It also passes into breast milk, so breastfeeding mothers should avoid use unless the benefit outweighs the risk and a healthcare professional advises otherwise.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Mel Med. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam offers a longer half‑life and greater COX‑2 selectivity compared with many traditional NSAIDs such as ibuprofen or naproxen, which may result in once‑daily dosing and a slightly lower risk of gastrointestinal irritation. However, cardiovascular and renal cautions remain similar across the class.

Mel Med should be stored at ambient temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, direct sunlight, and excessive heat to maintain stability and potency.

Mel Med is taken orally, usually with a full glass of water. It may be taken with or without food, but taking it with food can help reduce potential stomach upset. Follow the prescriber’s directions regarding timing and any dose adjustments.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe skin reactions, liver injury, and renal failure. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Meloxicam should be avoided in individuals with known hypersensitivity to meloxicam or other oxicam NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, recent coronary artery bypass graft surgery, and in patients with significant renal or hepatic impairment unless specifically directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meloxicam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT